🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Studying samples of tissue and bone marrow from patients with ca...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01358604
1. To determine the level of STAT4 expression in different cases of multipl...
Status
Completed
Location
Assiut University Hospital
Start Date
2019-09-20
Trial ID
NCT03893344
Treatments Being Tested
In this randomized controlled trial (RCT), severe cases of COVID-19 infecti...
Status
Completed
Location
Avicenna Research Institute
Start Date
2021-04-17
Trial ID
NCT05019287
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as fludarabine phosphate, work ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00845104
The primary objective of this study is to establish differences in suscepti...
Status
Completed
Location
Hospital Ramon y Cajal
Start Date
2020-08-01
Trial ID
NCT04402827
Treatments Being Tested
This is a prospective biological study evaluating the persistence of COVID-...
Status
Active Not Recruiting
Location
Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
Start Date
2024-05-07
Trial ID
NCT06070961
The goal of this observational study is to explore whether changes in perip...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07392073
Treatments Being Tested
Bone-marrow-derived progenitor cells (EPCS) play an important role in neova...
Status
Completed
Location
CHU limoges
Start Date
2009-03
Trial ID
NCT00826683
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and capecitabine...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00524069
The primary objective of this exploratory cohort study is to describe level...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01406483
Treatments Being Tested